BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8943868)

  • 1. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders.
    Miles DK; Freedman MH; Stephens K; Pallavicini M; Sievers EL; Weaver M; Grunberger T; Thompson P; Shannon KM
    Blood; 1996 Dec; 88(11):4314-20. PubMed ID: 8943868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.
    Shannon KM; O'Connell P; Martin GA; Paderanga D; Olson K; Dinndorf P; McCormick F
    N Engl J Med; 1994 Mar; 330(9):597-601. PubMed ID: 8302341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lineage acute lymphoblastic leukemia transformation in a child with juvenile myelomonocytic leukemia, type 1 neurofibromatosis and monosomy of chromosome 7. Possible implications in the leukemogenesis.
    Scrideli CA; Baruffi MR; Rogatto SR; Valera ET; Defavery R; Tone LG
    Leuk Res; 2003 Apr; 27(4):371-4. PubMed ID: 12531231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis.
    Shannon KM; Watterson J; Johnson P; O'Connell P; Lange B; Shah N; Steinherz P; Kan YW; Priest JR
    Blood; 1992 Mar; 79(5):1311-8. PubMed ID: 1536955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
    Side L; Taylor B; Cayouette M; Conner E; Thompson P; Luce M; Shannon K
    N Engl J Med; 1997 Jun; 336(24):1713-20. PubMed ID: 9180088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1.
    Luria D; Avigad S; Cohen IJ; Stark B; Weitz R; Zaizov R
    Cancer; 1997 Nov; 80(10):2013-8. PubMed ID: 9366306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.
    Side LE; Emanuel PD; Taylor B; Franklin J; Thompson P; Castleberry RP; Shannon KM
    Blood; 1998 Jul; 92(1):267-72. PubMed ID: 9639526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.
    Kalra R; Paderanga DC; Olson K; Shannon KM
    Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin remodeling gene SMARCA5 is dysregulated in primitive hematopoietic cells of acute leukemia.
    Stopka T; Zakova D; Fuchs O; Kubrova O; Blafkova J; Jelinek J; Necas E; Zivny J
    Leukemia; 2000 Jul; 14(7):1247-52. PubMed ID: 10914549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1.
    Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM
    Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
    Lapidot T; Grunberger T; Vormoor J; Estrov Z; Kollet O; Bunin N; Zaizov R; Williams DE; Freedman MH
    Blood; 1996 Oct; 88(7):2655-64. PubMed ID: 8839860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of juvenile myelomonocytic leukemia in a female patient with paternally inherited neurofibromatosis type 1.
    Leung EW; Vanek W; Abdelhaleem M; Freedman MH; Dror Y
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):145-7. PubMed ID: 12571467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations.
    Haase D; Feuring-Buske M; Könemann S; Fonatsch C; Troff C; Verbeek W; Pekrun A; Hiddemann W; Wörmann B
    Blood; 1995 Oct; 86(8):2906-12. PubMed ID: 7579382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia.
    Gitler AD; Kong Y; Choi JK; Zhu Y; Pear WS; Epstein JA
    Pediatr Res; 2004 Apr; 55(4):581-4. PubMed ID: 14739366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
    Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
    Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVI-1 gene expression in myeloid clonogenic cells from juvenile myelomonocytic leukemia (JMML).
    Privitera E; Longoni D; Brambillasca F; Biondi A
    Leukemia; 1997 Dec; 11(12):2045-8. PubMed ID: 9447818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.
    Kim A; Morgan K; Hasz DE; Wiesner SM; Lauchle JO; Geurts JL; Diers MD; Le DT; Kogan SC; Parada LF; Shannon K; Largaespada DA
    Blood; 2007 Feb; 109(4):1687-91. PubMed ID: 17090653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell.
    Cooper LJ; Shannon KM; Loken MR; Weaver M; Stephens K; Sievers EL
    Blood; 2000 Sep; 96(6):2310-3. PubMed ID: 10979983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.